Qtron Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,337
Closed -$367K 448
2022
Q3
$367K Buy
+2,337
New +$373K 0.09% 295
2022
Q1
Sell
-1,261
Closed -$274K 360
2021
Q4
$274K Buy
+1,261
New +$264K 0.06% 289
2021
Q1
Sell
-1,491
Closed -$208K 358
2020
Q4
$208K Sell
1,491
-342
-19% -$43.1K 0.06% 319
2020
Q3
$205K Buy
+1,833
New +$212K 0.07% 260
2019
Q4
Sell
-3,211
Closed -$270K 249
2019
Q3
$270K Buy
+3,211
New +$243K 0.16% 183
2019
Q2
Sell
-3,702
Closed -$218K 254
2019
Q1
$218K Buy
+3,702
New +$221K 0.2% 178

Other funds holding MEDP

Qtron Investments's MEDP Position: Q4 2022 in Review

Qtron Investments sold out of Medpace (MEDP) in Q4 2022, closing a stake of 2,337 shares — an estimated $367K sold.

Qtron Investments first reported a position in MEDP in Q1 2019 and held it in 6 quarters. The position peaked at $367K in Q3 2022. 422 funds tracked by Wall St. Rank hold MEDP as of Q4 2022.

  • Qtron Investments reported no remaining Medpace position as of Q4 2022 after selling out during the quarter.
  • Qtron Investments sold 2,337 Medpace shares in Q4 2022, an estimated $367K.
  • Qtron Investments first reported a position in Medpace in Q1 2019 and held it in 6 quarters.
  • Qtron Investments's Medpace position peaked at $367K in Q3 2022.
  • 422 funds tracked by Wall St. Rank held Medpace as of Q4 2022.

Based on Qtron Investments's 13F filing for Q4 2022, filed 13 Feb 2023.